Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-06
DOI
10.1038/s41467-021-22265-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
- (2020) Jeremy Chataway et al. LANCET NEUROLOGY
- Association between pathological and MRI findings in multiple sclerosis
- (2019) Massimo Filippi et al. LANCET NEUROLOGY
- Deep gray matter volume loss drives disability worsening in multiple sclerosis
- (2018) Arman Eshaghi et al. ANNALS OF NEUROLOGY
- Progression of regional grey matter atrophy in multiple sclerosis
- (2018) Arman Eshaghi et al. BRAIN
- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
- (2018) Raju Kapoor et al. LANCET NEUROLOGY
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
- (2018) Jerry S. Wolinsky et al. ANNALS OF NEUROLOGY
- Classification, Ontology, and Precision Medicine
- (2018) Melissa A. Haendel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference
- (2018) Alexandra L Young et al. Nature Communications
- Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study
- (2017) José M A Wijnands et al. LANCET NEUROLOGY
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- Multimodal population brain imaging in the UK Biobank prospective epidemiological study
- (2016) Karla L Miller et al. NATURE NEUROSCIENCE
- Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis
- (2015) Tanja Jürgens et al. BRAIN
- Exploring the origins of grey matter damage in multiple sclerosis
- (2015) Massimiliano Calabrese et al. NATURE REVIEWS NEUROSCIENCE
- White and gray matter damage in primary progressive MS
- (2015) Benedetta Bodini et al. NEUROLOGY
- Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
- (2015) Dalia L. Rotstein et al. JAMA Neurology
- A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis
- (2014) T. L. Vollmer et al. JOURNAL OF NEUROLOGY
- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
- (2014) Jeremy Chataway et al. LANCET
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- The WU-Minn Human Connectome Project: An overview
- (2013) David C. Van Essen et al. NEUROIMAGE
- A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology
- (2012) James Kolasinski et al. BRAIN
- Measurement and clinical effect of grey matter pathology in multiple sclerosis
- (2012) Jeroen JG Geurts et al. LANCET NEUROLOGY
- Will the real multiple sclerosis please stand up?
- (2012) Peter K. Stys et al. NATURE REVIEWS NEUROSCIENCE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longitudinal gray matter changes in multiple sclerosis-Differential scanner and overall disease-related effects
- (2011) Kerstin Bendfeldt et al. HUMAN BRAIN MAPPING
- A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
- (2011) M. S. Freedman et al. NEUROLOGY
- Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
- (2010) Raju Kapoor et al. LANCET NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started